A study analysing immune responses of BNT162b2 against SARS-CoV-2 B.1.1.7 variant
Latest Information Update: 25 May 2021
At a glance
- Drugs Tozinameran (Primary)
- Indications SARS-CoV-2 acute respiratory disease
- Focus Pharmacodynamics
- 25 May 2021 New trial record
- 01 May 2021 Results published in the Nature